VULTUS AB (V06) - Net Assets
Based on the latest financial reports, VULTUS AB (V06) has net assets worth €34.63 Million EUR (≈ $40.48 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€39.78 Million ≈ $46.50 Million USD) and total liabilities (€5.15 Million ≈ $6.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore V06 total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €34.63 Million |
| % of Total Assets | 87.05% |
| Annual Growth Rate | 76.97% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 563.41 |
VULTUS AB - Net Assets Trend (2021–2025)
This chart illustrates how VULTUS AB's net assets have evolved over time, based on quarterly financial data. Check V06 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for VULTUS AB (2021–2025)
The table below shows the annual net assets of VULTUS AB from 2021 to 2025. For live valuation and market cap data, see V06 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €34.63 Million ≈ $40.48 Million |
+1301.36% |
| 2024-12-31 | €2.47 Million ≈ $2.89 Million |
-52.47% |
| 2023-12-31 | €5.20 Million ≈ $6.08 Million |
-26.41% |
| 2022-12-31 | €7.06 Million ≈ $8.26 Million |
+100.10% |
| 2021-12-31 | €3.53 Million ≈ $4.13 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to VULTUS AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1550853200.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €34.63 Million | 100.00% |
| Total Equity | €34.63 Million | 100.00% |
VULTUS AB Competitors by Market Cap
The table below lists competitors of VULTUS AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Spectra7 Microsystems Inc
V:SEV
|
$1.15 Million |
|
ARMATURA S.A.
RO:ARM
|
$1.15 Million |
|
QUADRO RESOURCES LTD
F:G4O
|
$1.15 Million |
|
Baring Emerging Europe Plc
LSE:BEMO
|
$1.15 Million |
|
Goldhills Holding Ltd
V:GHL
|
$1.14 Million |
|
DELPHI WORLD MONEY LIMITED
NSE:DELPHIFX
|
$1.14 Million |
|
Starbox Group Holdings Ltd. Ordinary Shares
NASDAQ:STBX
|
$1.14 Million |
|
Universal Ibogaine Inc
V:IBO
|
$1.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in VULTUS AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,470,880 to 34,626,000, a change of 32,155,120 (1301.4%).
- Net loss of 3,187,000 reduced equity.
- Other factors increased equity by 35,342,120.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.19 Million | -9.2% |
| Other Changes | €35.34 Million | +102.07% |
| Total Change | €- | 1301.36% |
Book Value vs Market Value Analysis
This analysis compares VULTUS AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.79 | €0.00 | x |
| 2022-12-31 | €1.12 | €0.00 | x |
| 2023-12-31 | €0.33 | €0.00 | x |
| 2024-12-31 | €0.13 | €0.00 | x |
| 2025-12-31 | €0.11 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently VULTUS AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1539.61%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.15x
- Recent ROE (-9.20%) is above the historical average (-111.88%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -83.97% | -266.00% | 0.16x | 1.98x | €-3.32 Million |
| 2022 | -91.25% | -764.51% | 0.10x | 1.22x | €-7.15 Million |
| 2023 | -186.69% | -1205.72% | 0.12x | 1.33x | €-10.23 Million |
| 2024 | -188.27% | -263.17% | 0.32x | 2.23x | €-4.90 Million |
| 2025 | -9.20% | -1539.61% | 0.01x | 1.15x | €-6.65 Million |
Industry Comparison
This section compares VULTUS AB's net assets metrics with peer companies in the Information Technology Services industry.
Industry Context
- Industry: Information Technology Services
- Average net assets among peers: $312,561,078
- Average return on equity (ROE) among peers: -4.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| VULTUS AB (V06) | €34.63 Million | -83.97% | 0.15x | $1.14 Million |
| CLPS INC. DL-0001 (1UK) | $63.92 Million | -3.65% | 0.72x | $22.08 Million |
| Globant SA (2G2) | $208.56 Million | 17.20% | 0.37x | $1.38 Billion |
| Solutions 30 SE (30L3) | $124.70 Million | -18.20% | 4.80x | $64.24 Million |
| Genpact Limited (35G) | $1.29 Billion | 20.79% | 1.24x | $5.05 Billion |
| NANOSPHERE (3NS) | $-986.83K | 0.00% | 0.00x | $1.12 Million |
| BIT MINING C.A SP.ADR 100 (50C0) | $25.13 Million | -114.24% | 1.89x | $13.76 Million |
| WISE PLC SPONS.ADR/1 (6WS0) | $1.39 Billion | 30.06% | 12.88x | $9.95 Billion |
| GS TECHS LTD (DI) (6Y3) | $6.01 Million | -23.81% | 0.37x | $1.16 Million |
| CPT GLOBAL LTD (714) | $5.63 Million | 26.15% | 1.60x | $1.80 Million |
| PASSUS S.A. ZY-1 (71X) | $19.80 Million | 21.83% | 2.69x | $44.40 Million |
About VULTUS AB
C100 AB (publ) is public investment firm specializing in early stage and Emerging stage. The Firm prefers to invest in Technology and Life science Sector. The Firm Typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments. C100 AB (publ) is based in stockholm, Sweden.